Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Fluidx Medical Technology, Inc.
City of Hope Medical Center
iOmx Therapeutics AG
HiFiBiO Therapeutics
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris